$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
France is reopening its borders with the UK to lorry drivers who test negative for Covid-19
Retailer filled hundreds of thousands of illegitimate prescriptions, justice department claims
Two former board members tell Congress they do not bear personal responsibility for addiction epidemic
Claim relates to US settlement over past marketing of opioid addiction treatment Suboxone
Investigators must bring to book the highest profile perpetrators
Retailer claims authorities put its pharmacists in impossible position over prescriptions
Members of billionaire Sackler family to pay $225m in related civil settlement
All of the swagger of the speciality pharma group has disappeared
Access to a global network of round-the-clock meetings has been an unexpected boost for many in recovery
Resolution with justice department takes total paid over addiction treatment Suboxone to $2bn
Case against Shaun Thaxter is latest in crackdown by American prosecutors on industry
Why were the warning signs around Insys ignored for so long? The FT and PBS series ‘Frontline’ investigate
Trump administration makes it easier for addicts to obtain methadone and other treatment drugs
A memoir of a descent into drug abuse explores a hidden side of America’s opioid crisis
Prison time for Insys execs puts opioid makers on notice
Ex-Insys sales chief spoke to FT before former staff were sentenced this week
Consumer spending on many illegal substances grew rapidly after 1965
Some states have targeted family members in opioid lawsuits after company bankruptcy
The artist tells the FT why she ‘can’t stand back and watch another generation disappear’
Israeli drugmaker reports widening quarterly loss but lifts outlook
Four plaintiffs aim to persuade others to sign on to framework
Teva and distributors’ deal came as first federal trial on US addiction crisis was due to open
First federal lawsuit to proceed after local governments call offer ‘inadequate’
Opiod maker owned by Sackler family has yet to reach deal with all attorneys-general
International Edition
